Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170674 · ClinicalTrials.gov registry record · NA
CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette
A NA study of Smoking, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 2
- Study locations
NCT03170674: Completed NA study of Smoking, sponsored by RAI Services Company.
NCT03170674 is a NA study of Smoking that has completed, run by RAI Services Company. The registered enrollment target is 114 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03170674, a NA study of Smoking, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this clinical study is to evaluate changes in biomarkers of exposure (BOE) to tobacco smoke constituents after smokers switch from combustible cigarettes to use of one of the three electronic cigarettes or abstinence.
Primary Outcome
A comparison of biomarkers of tobacco exposure in urine from subjects at baseline and for 5 days after they have switched to one of the electronic cigarette products or abstinence. Biomarkers of tobacco exposure in urine include: 1. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (NNAL) + glucuronides 2. N'-nitrosonornicotine (NNN) + glucuronides 3. 4-aminobiphenyl 4. 1-aminonaphthalene 5. 2-aminonaphthalene 6. o-toluidine 7. S-phenyl mercapturic acid (SPMA) 8. 3-hydroxy-1-methylpropyl-mercaptu
Conditions Studied
Interventions
- OTHER FT21039
- OTHER FT21092
- OTHER FT21018
Study Locations (2)
Kansas
- Vince & Associates Clinical Research, Inc. - Overland Park
Minnesota
- DaVita Clinical Research - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2017-08-18 |
| Phase | NA |
What the finished NCT03170674 record still lists
NCT03170674 is an interventional study that assigns participants to a tested intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 3 interventions - of which FT21039 is the first listed.
NCT03170674 reports a single indexed study location in Kansas, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03170674 about?
NCT03170674 is a clinical study titled "CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette". The purpose of this clinical study is to evaluate changes in biomarkers of exposure (BOE) to tobacco smoke constituents after smokers switch from combustible cigarettes to use of one of the three electronic cigarettes or abstinence.
What is the current status of trial NCT03170674?
This trial is currently completed. It is a NA study. The enrollment target is 114 participants. The study started on 2017-05-15. Estimated completion is 2017-08-18.
What conditions does trial NCT03170674 study?
This clinical trial studies the following conditions: Smoking.
What interventions are being tested in trial NCT03170674?
The interventions under investigation include: FT21039 (OTHER), FT21092 (OTHER), FT21018 (OTHER).
Who is sponsoring clinical trial NCT03170674?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03170674 being conducted?
This trial has 2 study locations across Kansas, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03170674's enrollment target sits among peer trials
114 68th of 123 higher than 55 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI